These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6653671)

  • 41. Central opiate modulation of peripheral IL-6 in rats.
    Bertolucci M; Perego C; De Simoni MG
    Neuroreport; 1996 Apr; 7(6):1181-4. PubMed ID: 8817528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.
    Huidobro-Toro JP; Way EL
    Br J Pharmacol; 1981 Nov; 74(3):681-94. PubMed ID: 6170377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates. Heterogeneity in opioid mechanisms indicated.
    Neil A
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):50-3. PubMed ID: 7121611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
    Xu JY; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.
    Parolaro D; Sala M; Crema G; Spazzi L; Gori E
    Life Sci; 1983; 33 Suppl 1():485-8. PubMed ID: 6664230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for serotonergic system involvement in the effect of morphine on gastrointestinal motility in the rat.
    Pourgholami MH; Goshadrou F
    Gen Pharmacol; 1995 Jul; 26(4):779-83. PubMed ID: 7635252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone.
    Parolaro D; Sala M; Gori E
    Eur J Pharmacol; 1977 Dec; 46(4):329-38. PubMed ID: 590342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphine antinociception in different strains of mice: relationship of supraspinal-spinal multiplicative interaction to tolerance.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1988 Nov; 247(2):603-8. PubMed ID: 3183956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.
    Heyman JS; Vaught JL; Mosberg HI; Haaseth RC; Porreca F
    Eur J Pharmacol; 1989 Jun; 165(1):1-10. PubMed ID: 2548877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The possible involvement of adrenoceptors in the intestinal effect of morphine in mice.
    Wong CL
    Clin Exp Pharmacol Physiol; 1984; 11(6):605-10. PubMed ID: 6536420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
    Crain SM; Shen KF
    Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opiates and thermoregulation in mice. I. Agonists.
    Rosow CE; Miller JM; Pelikan EW; Cochin J
    J Pharmacol Exp Ther; 1980 May; 213(2):273-83. PubMed ID: 6154139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chlordiazepoxide antinociception: cross-tolerance with opiates and with stress.
    Bodnar RJ; Kelly DD; Thomas LW; Mansour A; Brutus M; Glusman M
    Psychopharmacology (Berl); 1980; 69(1):107-10. PubMed ID: 6771821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of aspirin and paracetamol on naloxone reversal of morphine-induced inhibition of gastrointestinal propulsion in mice.
    Wong CL; Wai MK
    Eur J Pharmacol; 1981 Jul; 73(1):11-9. PubMed ID: 7318887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerance to the respiratory actions of opiates: withdrawal tolerance and asymmetrical cross-tolerance.
    Ayesta FJ; Flórez J
    Eur J Pharmacol; 1990 Jan; 175(1):1-12. PubMed ID: 2138980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of morphine antinociception by ibogaine and noribogaine in morphine-tolerant mice.
    Sunder Sharma S; Bhargava HN
    Pharmacology; 1998 Nov; 57(5):229-32. PubMed ID: 9742287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal transit following intrathecal or subcutaneous narcotic analgesics.
    Dhasmana KM; Banerjee AK; Erdmann W
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):152-61. PubMed ID: 2884939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Megadoses of vitamin C prevent the development of tolerance and physical dependence on morphine in mice.
    Khanna NC; Sharma SK
    Life Sci; 1983; 33 Suppl 1():401-4. PubMed ID: 6686637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.
    Walker JR; King M; Izzo E; Koob GF; Pasternak GW
    Eur J Pharmacol; 1999 Oct; 383(2):115-9. PubMed ID: 10585524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.